Severe hemolysis and vasoclusive crisis due to COVID-19 infection in a
Sickle Cell Disease patient improved after Red Blood Cells exchange
- Lina Okar
, - Mohamad Rezek,
- Amna Gamil,
- Yahya Mulkandathil,
- mohamed yassin
Abstract
As the clinical course of COVID-19 infection in SCD patients is not
clear, close monitoring is essential. We emphasize that RBC exchange
should be offered early to avoid possible deterioration. We present a
case of COVID-19 infection in a SCD patient causing severe hemolysis,
that improved after RBC exchange.11 Dec 2020Submitted to Clinical Case Reports 14 Dec 2020Submission Checks Completed
14 Dec 2020Assigned to Editor
07 Jan 2021Reviewer(s) Assigned
22 Jan 2021Review(s) Completed, Editorial Evaluation Pending
22 Jan 2021Editorial Decision: Revise Minor
23 Jan 20211st Revision Received
26 Jan 2021Submission Checks Completed
26 Jan 2021Assigned to Editor
26 Jan 2021Review(s) Completed, Editorial Evaluation Pending
08 Feb 2021Editorial Decision: Accept
